Klinik und Poliklinik für Innere Medizin II, Klinikum Rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675, München, Germany.
Dig Dis Sci. 2022 Apr;67(4):1371-1378. doi: 10.1007/s10620-021-06945-z. Epub 2021 Mar 26.
Early identification of patients with acute severe pancreatitis is important for prompt and adequate treatment. Existing scores for pancreatitis are often laborious or require serial patient evaluation, whereas the qSOFA score, that was established to predict outcome in patients with suspected infection, is simple to perform.
In this cohort study, we analyse the potential of the qSOFA score to predict outcome of patients with acute pancreatitis and refine the qSOFA score by rapid available laboratory parameters to the emergency room assessment of acute pancreatitis (ERAP) score. Validation was performed in a separate patient cohort.
In total 203 patients with acute pancreatitis were recruited. The qSOFA score has the potential to predict ICU admission (AUC = 0.730, p = 0.002) and organ failure (AUC = 0.799, p = 0.013) in acute pancreatitis. Respiratory rate, mental status, blood urea nitrogen and C-reactive protein are the rapid available parameters with the highest individual impact in binary logistic regression analyses. Their combination to the ERAP score can predict severity of acute pancreatitis according to the revised Atlanta classification (AUC = 0.689 ± 0.041, p < 0.001), ICU admission (AUC = 0.789 ± 0.067, p < 0.001), multi-organ dysfunction syndrome (AUC = 0.963 ± 0.024, p < 0.001) and mortality (AUC = 0.952 ± 0.028, p = 0.001). The performance and prognostic validity for organ failure and mortality were validated in an independent patient cohort.
The qSOFA is a rapidly available prognostic score in acute pancreatitis with limited prognostic validity. A combination with the laboratory parameters BUN and CRP results in the new ERAP score with outstanding prognostic validity for multi-organ dysfunction syndrome and mortality.
早期识别急性重症胰腺炎患者对于及时、充分的治疗非常重要。现有的胰腺炎评分往往繁琐或需要连续的患者评估,而 qSOFA 评分是为预测疑似感染患者的预后而建立的,操作简单。
在这项队列研究中,我们分析了 qSOFA 评分预测急性胰腺炎患者预后的潜力,并通过急诊评估急性胰腺炎时的快速可得实验室参数对 qSOFA 评分进行了细化,得到了 ERAP 评分。在另一个患者队列中进行了验证。
共纳入 203 例急性胰腺炎患者。qSOFA 评分有预测 ICU 收治(AUC=0.730,p=0.002)和器官衰竭(AUC=0.799,p=0.013)的潜力。在二项逻辑回归分析中,呼吸频率、精神状态、血尿素氮和 C 反应蛋白是具有最高个体影响的快速可得参数。它们与 ERAP 评分的组合可根据修订后的亚特兰大分类预测急性胰腺炎的严重程度(AUC=0.689±0.041,p<0.001)、ICU 收治(AUC=0.789±0.067,p<0.001)、多器官功能障碍综合征(AUC=0.963±0.024,p<0.001)和死亡率(AUC=0.952±0.028,p=0.001)。在一个独立的患者队列中验证了器官衰竭和死亡率的性能和预后有效性。
qSOFA 是急性胰腺炎中一种快速可得的预后评分,其预后有效性有限。与 BUN 和 CRP 等实验室参数相结合,得到了新的 ERAP 评分,对多器官功能障碍综合征和死亡率具有出色的预后有效性。